Bottom line
What does FXH hold?
FXH held 75 positions as of Jul 31, 2026. Its largest holding is Regeneron Pharmaceuticals Inc at 2.77% of the fund, and the top 10 positions add up to 24.6%. By asset type it is 100% stocks, 0% cash & short-term funds.
Updated Sep 22, 2026
FXH top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | Regeneron Pharmaceuticals Inc REGN REGENERON PHARMACEUTICALS INC COM |
Stocks | 2.77% | $29.0M |
| 2 | Universal Health Services Inc UHS UNIVERSAL HEALTH SERVICES INC CL B |
Stocks | 2.57% | $26.9M |
| 3 | Solventum Corp SOLV SOLVENTUM CORP COM SHS |
Stocks | 2.51% | $26.3M |
| 4 | Boston Scientific Corp BSX BOSTON SCIENTIFIC CORP COM |
Stocks | 2.48% | $26.0M |
| 5 | Zimmer Biomet Holdings Inc ZBH ZIMMER BIOMET HOLDINGS INC COM |
Stocks | 2.47% | $25.9M |
| 6 | Guardant Health Inc GH GUARDANT HEALTH INC COM |
Stocks | 2.45% | $25.6M |
| 7 | Davita Inc DVA DAVITA INC COM |
Stocks | 2.44% | $25.6M |
| 8 | Pfizer Inc PFE PFIZER INC COM |
Stocks | 2.35% | $24.6M |
| 9 | Tenet Healthcare Corp THC TENET HEALTHCARE CORP COM NEW |
Stocks | 2.30% | $24.1M |
| 10 | Cigna Group (the) CI CIGNA GROUP (THE) COM |
Stocks | 2.29% | $24.0M |
| 11 | Globus Medical Inc GMED GLOBUS MEDICAL INC CL A |
Stocks | 2.26% | $23.7M |
| 12 | Medline Inc MDLN MEDLINE INC COM CL A |
Stocks | 2.26% | $23.6M |
| 13 | Natera Inc NTRA NATERA INC COM |
Stocks | 2.23% | $23.4M |
| 14 | Corcept Therapeutics Inc CORT CORCEPT THERAPEUTICS INC COM |
Stocks | 2.23% | $23.3M |
| 15 | Centene Corp CNC CENTENE CORP COM |
Stocks | 2.20% | $23.0M |
| 16 | Axsome Therapeutics Inc AXSM AXSOME THERAPEUTICS INC COM |
Stocks | 2.02% | $21.1M |
| 17 | Encompass Health Corp EHC ENCOMPASS HEALTH CORP COM |
Stocks | 1.86% | $19.5M |
| 18 | Medtronic Plc MDT MEDTRONIC PLC SHS |
Stocks | 1.85% | $19.3M |
| 19 | Resmed Inc RMD RESMED INC COM |
Stocks | 1.83% | $19.2M |
| 20 | Zoetis Inc ZTS ZOETIS INC CL A |
Stocks | 1.82% | $19.1M |
| 21 | Qiagen Nv QGEN QIAGEN NV ORD SHARES |
Stocks | 1.79% | $18.8M |
| 22 | Halozyme Therapeutics Inc HALO HALOZYME THERAPEUTICS INC COM |
Stocks | 1.78% | $18.7M |
| 23 | Incyte Corp INCY INCYTE CORP COM |
Stocks | 1.78% | $18.7M |
| 24 | Arrowhead Pharmaceuticals Inc ARWR ARROWHEAD PHARMACEUTICALS INC COM |
Stocks | 1.76% | $18.4M |
| 25 | Neurocrine Biosciences Inc NBIX NEUROCRINE BIOSCIENCES INC COM |
Stocks | 1.67% | $17.5M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 22, 2026